Market Movers

Eli Lilly and Company (LLY)

923.71 USD -11.31 (-1.21%) Volume: 2.04M

Eli Lilly and Company’s stock price stands at 923.71 USD, experiencing a slight dip of -1.21% this trading session. Despite the recent drop, LLY’s trading volume remains robust at 2.04M. The pharmaceutical giant’s stock has displayed remarkable resilience with a year-to-date increase of +58.46%, making it a noteworthy performer in the market.

Latest developments on Eli Lilly and Company

Eli Lilly & Company has made significant strides in expanding its manufacturing capabilities with a $1.8 billion investment in Ireland, focusing on scaling up production of drugs for Alzheimer’s, obesity, and diabetes. The pharmaceutical giant also received FDA approval for its eczema drug, EBGLYSS™, further solidifying its position in the market. With positive phase 3 results for a weekly insulin formulation and a Buy rating from Citi, Eli Lilly’s stock price has seen gains as investors show confidence in the company’s growth prospects. This expansion in Ireland marks a strategic move for Eli Lilly as it continues to innovate and deliver groundbreaking solutions in the healthcare industry.

A look at Eli Lilly and Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for Eli Lilly & Company, the company seems to have a positive long-term outlook. With a high momentum score of 4, it indicates that the company is performing well in terms of stock price performance and market trends. Additionally, a growth score of 3 suggests that Eli Lilly & Company is positioned for future expansion and development. While the value, dividend, and resilience scores are not as high, the overall outlook for the company appears to be promising.

Eli Lilly & Company is a pharmaceutical company that focuses on discovering, developing, manufacturing, and selling products for both humans and animals. With a diverse range of products in areas such as neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health, the company has a strong presence in markets worldwide. The Smartkarma Smart Scores provide insight into the company’s performance in key areas, indicating a positive momentum and growth outlook for Eli Lilly & Company in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biogen Inc. (BIIB)

195.63 USD -2.26 (-1.14%) Volume: 1.09M

Biogen Inc.’s stock price stands at 195.63 USD, witnessing a dip of -1.14% this trading session with a trading volume of 1.09M, reflecting a significant YTD decrease of -24.40%, a trend that potential investors should keep an eye on in the pharmaceutical industry’s fluctuating market.

Latest developments on Biogen Inc.

Biogen’s stock price experienced a 2.3% decline today following the news that the company’s Tofersen drug did not receive UK approval filing due to a decision by NICE HTA. Despite this setback, the company made strategic moves by appointing two new independent directors to its board, enhancing its expertise with medical experts. The addition of Minor and Pangalos to the board comes as Biogen continues to expand its leadership team. Additionally, C4 Therapeutics delivered a second Bidac degrader to Biogen, signaling potential developments in the company’s pipeline. These events have contributed to the fluctuations in Biogen’s stock price and market performance.

A look at Biogen Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Biogen Inc., a company specializing in therapies for neurological, oncological, and immunological conditions, has received a strong overall outlook based on Smartkarma Smart Scores. With a high Value score, Biogen is seen as a solid investment option. However, the company’s low Dividend score may deter investors seeking regular income. Despite this, Biogen’s moderate scores in Growth and Momentum indicate potential for future development and market performance.

Biogen Inc.’s resilience score, though not as high as its Value score, suggests the company’s ability to withstand challenges and maintain stability in the long term. This, coupled with its favorable scores in Growth and Momentum, paints a promising outlook for the company’s future prospects. With a diverse range of products targeting various diseases, including multiple sclerosis and rheumatoid arthritis, Biogen is well-positioned to continue its growth and innovation in the healthcare industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

First Solar, Inc. (FSLR)

228.79 USD -7.16 (-3.03%) Volume: 2.17M

First Solar, Inc.’s stock price is currently trading at 228.79 USD, experiencing a slight dip of -3.03% this trading session, yet boasting a notable +32.80% year-to-date increase, with a substantial trading volume of 2.17M, demonstrating the stock’s significant market activity and investor interest.

Latest developments on First Solar, Inc.

First Solar Inc stock experienced a significant 15% surge in price today, following a wave of positive news and market movements. The company’s stock price had been sinking amidst overall market gains, but recent developments have sparked investor interest. Alternative energy stocks, including First Solar, saw a jump in prices on Wednesday, with solar stocks trading higher after the presidential debate. Hedge funds are eyeing First Solar as a potentially cheap clean energy stock to buy, indicating growing confidence in the company’s future prospects. With smart money betting big on FSLR options and post-debate optimism fueling the solar industry, First Solar Inc is poised for continued volatility and potential growth.

First Solar, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma are bullish on First Solar Inc., as indicated by their coverage of the company’s domestic market expansion and production capacity. In their report titled “First Solar Inc.: Domestic Market Expansion Through Government Incentives & Other Major Drivers,” they highlight the company’s strong performance in the second quarter of 2024, showcasing solid operating and financial results. Despite external uncertainties, such as policy changes and supply conditions, Baptista Research sees ongoing efforts by First Solar to strengthen its business fundamentals.

Furthermore, Baptista Research‘s report “First Solar Inc.: Expansion of Production Capacity & Expected Impact On The Top-Line! – Major Drivers” underscores the company’s robust performance in the first quarter of 2024. With a focus on increasing production capacity and improving competitiveness by 2030, First Solar aims to bolster growth and financial performance. The analysts note the company’s strong operating performance and plans to expand manufacturing facilities, emphasizing a positive outlook for the company’s future prospects.

A look at First Solar, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

First Solar Inc has a promising long-term outlook according to Smartkarma Smart Scores. With high scores in Growth and Resilience, the company is positioned for future expansion and stability. The company’s focus on designing and manufacturing solar modules using innovative technology gives it a competitive edge in the renewable energy sector.

Although First Solar Inc scores lower in Dividend, the overall outlook remains positive with solid scores in Value and Momentum. Investors can expect the company to continue its growth trajectory and maintain its resilience in the face of market challenges. With a strong emphasis on sustainability and clean energy solutions, First Solar Inc is well-positioned for long-term success in the industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Norfolk Southern Corporation (NSC)

245.80 USD -8.79 (-3.45%) Volume: 2.45M

“Norfolk Southern Corporation’s stock price stands at 245.80 USD, experiencing a downturn of -3.45% in the latest trading session with a volume of 2.45M shares traded. Despite the recent decline, NSC’s year-to-date performance remains positive, showing a gain of +3.99%.”

Latest developments on Norfolk Southern Corporation

Norfolk Southern made headlines today as CEO Alan Shaw was fired for engaging in an inappropriate relationship with the railroad’s chief legal officer, leading to his dismissal after an ethics investigation. In the wake of this scandal, CFO Mark George has been elevated to the top job, taking over as president and CEO. The company’s board of directors unanimously voted for this leadership change, aiming to prioritize operational excellence under the new CEO’s guidance. This sudden shift in leadership comes after reports of Shaw’s misconduct and violation of company ethics, causing turmoil within the organization. Despite the shakeup, Norfolk Southern seeks to reassure employees and move forward from the recent events that have unfolded.

Norfolk Southern Corporation on Smartkarma

Analysts at Baptista Research have been closely following Norfolk Southern Corporation, a major player in the transportation industry. In their recent research reports, they highlighted the company’s focus on leveraging intermodal strengths to drive growth and enhance operational efficiencies. President and CEO Alan Shaw led the discussion on the company’s second-quarter financial results, showcasing a significant improvement in operating ratio by 480 basis points sequentially. Despite ongoing challenges, Norfolk Southern is making notable advances in its operational strategies.

Furthermore, Baptista Research‘s analysis of Norfolk Southern‘s performance in previous quarters revealed a strategic focus on enhancing operational efficiency and productivity. The company’s balanced approach towards top-tier earnings, competitive margins, customer service, and growth with strong safety measures has been commendable. Despite facing network disruptions and market challenges, Norfolk Southern has shown resilience and commitment to maintaining a safe and efficient transportation network in North America. Analyst sentiment leans bullish on the company’s expansion and investment in intermodal operations, emphasizing its long-term growth potential.

A look at Norfolk Southern Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

According to Smartkarma Smart Scores, Norfolk Southern Corporation has a positive long-term outlook based on its overall scores. The company received high scores in Dividend and Momentum, indicating a strong performance in these areas. Norfolk Southern‘s ability to provide consistent dividend payouts and its strong momentum in the market are positive indicators for investors looking for stability and growth potential.

However, Norfolk Southern scored lower in Resilience, suggesting some potential vulnerabilities in the face of market fluctuations. With moderate scores in Value and Growth, the company may need to focus on improving these areas to enhance its long-term prospects. Overall, Norfolk Southern‘s strategic position in providing rail transportation services across key regions in the United States remains a key strength for its future growth and success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Moderna, Inc. (MRNA)

68.28 USD -1.40 (-2.01%) Volume: 11.96M

Moderna, Inc.’s stock price stands at 68.28 USD, witnessing a decrease of 2.01% this trading session with a trading volume of 11.96M. The biotechnology company’s year-to-date performance reflects a notable decline of 31.34%, making it a crucial point of interest for investors tracking the healthcare sector.

Latest developments on Moderna, Inc.

Moderna’s stock price took a hit today as the company announced significant cuts to its research and development budget, slashing $1.1 billion in spending. The decision comes as Moderna faces challenges with disappointing COVID-19 vaccine sales and delays in achieving its break-even goal. Analysts have downgraded the stock following the news, expressing concerns about the company’s profitability and future prospects. Despite the setbacks, Moderna remains focused on advancing its pipeline, with plans to launch a skin cancer vaccine by 2025. The company’s CEO also aims to submit a combination COVID and flu shot for FDA approval by the end of the year, showcasing Moderna’s ongoing commitment to innovation in the healthcare sector.

Moderna, Inc. on Smartkarma

Analysts at Baptista Research have been closely following Moderna on Smartkarma, an independent investment research network. In their report titled “Moderna Inc.: These Are The 4 Biggest Challenges That Bears Are Counting On! – Major Drivers,” the analysts lean towards a bullish sentiment. Moderna’s recent Quarterly Earnings showed positive advancements in its respiratory vaccine portfolio, especially with mRNA-1273, the COVID-19 vaccine, and a new RSV vaccine, mRESVIA. The analysts highlight the significant role of mRNA-1273 in combating COVID-19, with high hospitalization rates reported for the ’23/’24 season by the CDC.

Another report by Baptista Research on Smartkarma, titled “Moderna Inc.: Progress in Personalized Cancer Vaccine (PCV) Manufacturing & Other Major Developments,” also showcases a bullish sentiment towards Moderna. The first quarter 2024 financial results and business updates indicate positive progress in the company’s development of vaccines. Moderna’s COVID vaccines have already impacted millions of people, and ongoing Phase III studies are expected to reach many more. In the first quarter, the company made significant clinical progress with data presentations on Epstein-Barr virus (EBV), Varicella Zoster Virus (VZV), and Norovirus, showing promising advancements in the field of vaccine development.

A look at Moderna, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Moderna shows a promising long-term outlook. The company scores well in resilience, indicating its ability to withstand market fluctuations and challenges. Additionally, Moderna scores moderately in value, growth, and momentum. With a focus on developing mRNA therapeutics and vaccines for various diseases, including infectious and cardiovascular diseases, Moderna’s innovative approach positions it well for future growth and success.

Although Moderna scores low in the dividend category, its strengths in other areas suggest a positive trajectory for the company. As a biotechnology company with a focus on cutting-edge research and development, Moderna’s strategic positioning in the healthcare industry bodes well for its long-term prospects. Investors and analysts may find Moderna to be a compelling investment opportunity based on its overall Smartkarma Smart Scores and its commitment to advancing mRNA medicines for critical health issues.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Garmin Ltd. (GRMN)

172.68 USD -9.33 (-5.13%) Volume: 2.02M

Garmin Ltd.’s stock price stands at 172.68 USD, experiencing a dip of -5.13% this trading session, with a substantial trading volume of 2.02M. Despite the recent drop, GRMN’s year-to-date performance showcases a robust gain of +34.34%, highlighting its strong market resilience.

Latest developments on Garmin Ltd.

Garmin Ltd. is currently facing margin headwinds amidst concerns of being overvalued, leading to a rise in stock prices on Thursday that still underperforms the market. Despite this, Vest Financial LLC has raised its stock position in Garmin Ltd. on the NYSE under the ticker symbol GRMN, while Andra AP fonden has made a new investment in the company, indicating continued investor interest in the stock.

Garmin Ltd. on Smartkarma

Analysts at Baptista Research on Smartkarma have provided bullish insights on Garmin Ltd, a well-known player in the technology and gadget industry. In their report titled “Garmin Ltd.: Is The Focus on High Margin and High Growth Segments Paying Off? – Major Drivers”, the analysts highlighted the company’s commendable double-digit growth in consolidated revenue and operating income for the second quarter of 2024. With a 14% increase in consolidated revenue to $1.51 billion, Garmin Ltd set a new record for the second quarter, driven by the strong performance of three key business segments.

Furthermore, Baptista Research‘s report “Garmin Ltd.: Engagement in Strategic Acquisitions and Investments In the Business! – Major Drivers” revealed that Garmin Limited continued its positive momentum into the first quarter of 2024. The company reported a 20% increase in consolidated revenue to $1.38 billion, setting a new first quarter record. Additionally, four segments experienced double-digit growth, with gross and operating margins expanding year-over-year. These reports indicate a positive outlook for Garmin Ltd as it focuses on high-margin and high-growth segments to drive its business forward.

A look at Garmin Ltd. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Garmin Ltd, a company known for its navigation and communication devices, has received positive ratings across various factors according to Smartkarma Smart Scores. With high scores in resilience and momentum, the company seems well-positioned for long-term success. Its focus on innovation and adaptability has helped it maintain a strong presence in the market.

Although Garmin Ltd has average scores in value, dividend, and growth, its overall outlook remains positive. The company’s ability to withstand challenges and its strong momentum indicate a promising future. With a solid foundation in GPS technology, Garmin Ltd continues to develop and market products that meet the evolving needs of consumers.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

American Airlines Group Inc. (AAL)

10.69 USD -0.19 (-1.75%) Volume: 36.87M

American Airlines Group Inc.’s stock price is currently at 10.69 USD, experiencing a dip of 1.75% in this trading session with a trading volume of 36.87M. The stock has seen a significant decline of 22.20% Year-To-Date (YTD), reflecting the challenging market conditions for the aviation sector.

Latest developments on American Airlines Group Inc.

American Airlines Group stock price experienced fluctuations today amidst various events. The company’s flight attendants ratified a new agreement, signaling positive developments within the airline. Additionally, there were multiple reminders and alerts to investors regarding class action lawsuits against American Airlines Group Inc., urging them to take action before the deadlines. Despite this, analysts raised Q2 2025 EPS estimates for the company, showing potential growth. Furthermore, ZeroAvia’s recent financing, with investments from Airbus and American Airlines, could impact the stock price. Overall, the approval of a new contract and advancements in carbon removal technologies demonstrate a positive outlook for American Airlines Group.

A look at American Airlines Group Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for American Airlines Group, the company has a strong outlook for growth and resilience. With a score of 5 in both categories, this indicates that American Airlines Group is positioned well for future expansion and has the ability to withstand economic challenges. This is positive news for investors looking for long-term stability and potential returns in the airline industry.

While American Airlines Group may not score as highly in value or dividend payouts, its high scores in growth and resilience suggest a promising future. With a momentum score of 3, the company is also showing signs of positive movement. Overall, American Airlines Group appears to be a solid choice for investors seeking growth opportunities and a strong presence in the airline market.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

The Boeing Company (BA)

156.77 USD -6.00 (-3.69%) Volume: 18.94M

The Boeing Company’s stock price is currently standing at 156.77 USD, marking a decline of -3.69% this trading session with a trading volume of 18.94M, reflecting a significant drop of -39.86% YTD, indicating a challenging economic landscape for BA.

Latest developments on The Boeing Company

Boeing Co is facing a stock price movement today as 33,000 factory workers have gone on strike after rejecting contract negotiations. This marks the first strike by Boeing workers since 2008, posing challenges to production and supply chain targets. Moody’s has even warned of a potential credit rating downgrade for Boeing due to the strike’s impact on the company’s operations. Boeing says it is ready to negotiate a new agreement with the workers as the strike continues to affect its cash flow and production capabilities.

The Boeing Company on Smartkarma

Analysts from Baptista Research have provided insightful coverage on Boeing Co on Smartkarma. In their report titled “Boeing’s Rocky Runway: Is It Worth the Risk?”, they highlight the aerospace giant’s recent challenges despite its strong market position and backlog of orders. Issues such as manufacturing defects, regulatory scrutiny, and program delays are causing concern among investors. The report leans towards a bearish sentiment, suggesting turbulent times ahead for Boeing.

Another report by Baptista Research on Smartkarma focuses on “The Boeing Company: Will The Strategic Acquisition of Spirit Pay Off? – Major Drivers”. This report discusses Boeing’s actions post the Alaska Airlines accident in January, emphasizing CEO Dave Calhoun’s commitment to quality and safety measures. The company has made improvements in production protocols and compliance with FAA directives, signaling a positive outlook for Boeing. The report leans towards a bullish sentiment, highlighting potential growth opportunities for the aerospace company.

A look at The Boeing Company Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Boeing Co has a promising long-term outlook. With high scores in Growth and Resilience, the company is positioned to expand and withstand economic challenges. The strong momentum score also indicates positive market sentiment towards Boeing Co. However, the low score in Value suggests that the stock may be overvalued compared to its peers. Investors should consider these factors when evaluating the investment potential of Boeing Co.

The Boeing Company is a global leader in the development and production of commercial jet aircraft, as well as defense and space systems. With a focus on growth and resilience, Boeing Co is well-positioned to capitalize on opportunities in the aerospace industry. The company’s solid dividend score also indicates a commitment to rewarding shareholders. Overall, Boeing Co‘s Smartkarma Smart Scores paint a picture of a company with strong growth prospects and the ability to weather market fluctuations.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Axon Enterprise, Inc. (AXON)

379.61 USD -4.90 (-1.27%) Volume: 0.5M

Explore Axon Enterprise, Inc.’s stock price performance, currently at 379.61 USD, witnessing a slight dip of -1.27% this trading session with a trading volume of 0.5M. However, it showcases robust growth YTD with a percentage increase of +46.95%, making AXON a compelling consideration for investors.

Latest developments on Axon Enterprise, Inc.

A series of insider sales at Axon Enterprise Inc (AXON) have raised eyebrows recently, with COO & CFO Brittany Bagley selling 4,338 shares of company stock totaling $1.64 million. Despite this, the company’s stock price reached a new 12-month high following an analyst upgrade. The market responded positively, with Axon Enterprise gaining 5% today. The increase in trading volume and the acquisition of shares by investment partners further indicate a positive outlook for the public safety holding company. With the price target raised to $430, Axon Enterprise (NASDAQ:AXON) is definitely a stock worth keeping an eye on.

Axon Enterprise, Inc. on Smartkarma

Analysts on Smartkarma, such as Business Breakdowns, have published research on Axon Enterprise. In their report titled “Axon: Stunning The Competition – [Business Breakdowns, EP.175]”, they highlight Axon’s evolution from a taser pioneer to a provider of public safety technology ecosystem. The report mentions Axon’s focus on solving key issues in public safety, such as reducing officer and suspect fatalities from gunshots. With a bullish sentiment, the analysts emphasize Axon’s monopoly in providing TASERs globally as a non-lethal alternative to firearms.

The research report by Business Breakdowns on Smartkarma provides insights into Axon Enterprise’s innovative solutions for law enforcement and defense industries. By offering TASERs, body-worn cameras, and evidence software, Axon aims to address crucial challenges in public safety. The analysts highlight Axon’s role in minimizing physical harm during suspect apprehension through the use of TASERs. With a positive outlook on Axon’s market position, the report underscores the company’s commitment to enhancing public safety through advanced technology.

A look at Axon Enterprise, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Axon Enterprise has a promising long-term outlook. With high scores in Growth and Momentum, the company is expected to see significant expansion and positive market performance in the future. Additionally, its Resilience score indicates a strong ability to withstand economic challenges, further solidifying its position in the industry.

Although Axon Enterprise has lower scores in Value and Dividend, the overall outlook remains positive due to its strengths in Growth, Resilience, and Momentum. As a public safety technology company serving customers globally, Axon Enterprise is well-positioned to continue providing innovative solutions for law enforcement, military, and self-defense needs.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Micron Technology, Inc. (MU)

91.22 USD +4.01 (+4.60%) Volume: 20.87M

Micron Technology, Inc.’s stock price is currently performing strongly at 91.22 USD, marking a positive trading session increase of +4.60%. With a substantial trading volume of 20.87M and an impressive YTD percentage change of +6.89%, MU stock demonstrates promising investment potential.

Latest developments on Micron Technology, Inc.

Recent events have led to fluctuations in Micron Technology (NASDAQ:MU) stock price. Analysts have revised their price targets following a post-earnings slump, leading to a double downgrade and cuts in price targets. Despite this, some analysts believe that the slower growth is temporary. Additionally, President Trump’s comments about chip manufacturing have raised questions about Micron’s role in the industry. On the positive side, BlackRock considers Micron a significant AI stock, while Jim Cramer sees an opportunity in the company’s stock amidst the market volatility. Nonprofit capital investment has also been highlighted as a key factor in connecting Micron to the community. Overall, Micron’s stock price movements today seem to be influenced by a mix of analyst opinions, market trends, and industry developments.

Micron Technology, Inc. on Smartkarma

Analysts on Smartkarma are closely monitoring Micron Technology, with a mix of bullish and bearish sentiments. Baptista Research delves into the company’s expansion into data center and AI markets, highlighting key drivers that could impact its future stock price. Vincent Fernando, CFA, takes a positive stance, discussing the positive implications for the industry despite falling share prices. On the contrary, Jim Handy adopts a bearish view, warning about potential market collapse due to double-ordering. Additionally, William Keating anticipates a significant revenue jump for Micron’s HBM technology, projecting a record revenue year in 2025.

A look at Micron Technology, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for Micron Technology, the company seems to have a positive long-term outlook. With a high score in the Value category, it indicates that the company is considered undervalued and has potential for growth. Additionally, Micron Technology scored moderately in Resilience, suggesting that it is able to weather economic downturns and market volatility. However, the company scored lower in Dividend and Growth, indicating that it may not be a top performer in these areas. Overall, the Smart Scores paint a picture of a company with strong value potential and resilience in the market.

Micron Technology, Inc. is a company that specializes in manufacturing and marketing various semiconductor components, including DRAMs, SRAMs, Flash Memory, and memory modules. Despite scoring lower in the Dividend and Growth categories according to Smartkarma Smart Scores, Micron Technology has shown strength in value and resilience. This suggests that while the company may not be a top performer in terms of dividends and growth, it still has the potential for long-term success in the market. Investors may find Micron Technology to be a solid choice for their portfolios based on these factors.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma